Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2019 Nov;7(11):e877.
doi: 10.1002/mgg3.877. Epub 2019 Sep 11.

Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients

Affiliations

Glycogen storage diseases: Twenty-seven new variants in a cohort of 125 patients

Fernanda Sperb-Ludwig et al. Mol Genet Genomic Med. 2019 Nov.

Abstract

Background: Hepatic glycogen storage diseases (GSDs) are a group of rare genetic disorders in which glycogen cannot be metabolized to glucose in the liver because of enzyme deficiencies along the glycogenolytic pathway. GSDs are well-recognized diseases that can occur without the full spectrum, and with overlapping in symptoms.

Methods: We analyzed a cohort of 125 patients with suspected hepatic GSD through a next-generation sequencing (NGS) gene panel in Ion Torrent platform. New variants were analyzed by pathogenicity prediction tools.

Results: Twenty-seven new variants predicted as pathogenic were found between 63 variants identified. The most frequent GSD was type Ia (n = 53), followed by Ib (n = 23). The most frequent variants were p.Arg83Cys (39 alleles) and p.Gln347* (14 alleles) in G6PC gene, and p.Leu348Valfs (21 alleles) in SLC37A4 gene.

Conclusions: The study presents the largest cohort ever analyzed in Brazilian patients with hepatic glycogenosis. We determined the clinical utility of NGS for diagnosis. The molecular diagnosis of hepatic GSDs enables the characterization of diseases with similar clinical symptoms, avoiding hepatic biopsy and having faster results.

Keywords: glycogen storage disease; hepatic GSD; molecular diagnosis; next-generation sequencing.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment in

Similar articles

Cited by

References

    1. Adhikari, K. , Chacón‐Duque, J. C. , Mendoza‐Revilla, J. , Fuentes‐Guajardo, M. , & Ruiz‐Linares, A. (2017). The genetic diversity of the Americas. Annual Review of Genomics and Human Genetics, 18, 277–296. 10.1146/annurev-genom-083115-022331 - DOI - PubMed
    1. Adzhubei, I. A. , Schmidt, S. , Peshkin, L. , Ramensky, V. E. , Gerasimova, A. , Bork, P. , … Sunyaev, S. R. (2010). A method and server for predicting damaging missense mutations. Nature Methods, 7(4), 248–249. 10.1038/nmeth0410-248 - DOI - PMC - PubMed
    1. Akanuma, J. , Nishigaki, T. , Fujii, K. , Matsubara, Y. , Inui, K. , Takahashi, K. , … Narisawa, K. (2000). Glycogen storage disease type Ia: Molecular diagnosis of 51 Japanese patients and characterization of slicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells. American Journal of Medical Genetics, 91, 107–112. 10.1002/(SICI)1096-8628(20000313)91:2<107::AID-AJMG5>3.0.CO;2-Y - DOI - PubMed
    1. Bali, D. S. , Chen, Y. T. , Austin, S. , & Goldstein, J. L. (2016). Glycogen storage disease type I. Retrieved from https://www.ncbi.nlm.nih.gov/books/NBK1312/#_NBK1312_pubdet_
    1. Ban, K. , Sugiyama, K. , Goto, K. , Mizutani, F. , & Togari, H. (2003). Detection of PHKA2 gene mutation in four Japanese patients with hepatic phosphorylase kinase deficiency. Tohoku Journal of Experimental Medicine, 200, 47–53. 10.1620/tjem.200.47 - DOI - PubMed

Publication types